miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1

Background: Nowadays, microRNAs (miRNAs) attract much attention in regulating anticancer drug resistance in cancers including multiple myeloma (MM). Bortezomib is the first-line choice in MM treatment, and bortezomib resistance caused by aberrant DNA repair leads to the recurrence and therapeutic fa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Cycle
Main Authors: Yuan, Xiaoli, Ma, Rongjun, Yang, Shiwei, Jiang, Li, Wang, Zhen, Zhu, Zunmin, Li, Hongwei
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6619958/
https://ncbi.nlm.nih.gov/pubmed/31204563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2019.1632138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados